S'abonner

Staphylococcus Aureus Bacteremia Among Patients with Health Care-associated Fever - 12/08/11

Doi : 10.1016/j.amjmed.2008.09.040 
Martin E. Stryjewski, MD, MHS a, d, , Zeina A. Kanafani, MD e, Vivian H. Chu, MD a, b, Paul A. Pappas, MS a, Tina Harding, BSN a, Laura A. Drew, RN, BSN a, Daniel K. Benjamin, MD, PhD, MHS a, c, L. Barth Reller, MD b, Benjamin A. Lee, BA a, G. Ralph Corey, MD a, b, Vance G. Fowler, MD, MHS a, b
a Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 
b Department of Medicine, Duke University Medical Center, Durham, NC 
c Department of Pediatrics, Duke University Medical Center, Durham, NC 
d Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno” (CEMIC), Buenos Aires, Argentina 
e Division of Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon 

Requests for reprints should be addressed to Martin E. Stryjewski, MD, MHS, Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno”, Azcuenaga 1757, Apt 1C, Capital Federal (C1128AAC), Buenos Aires, Argentina

Abstract

Background

Although Staphylococcus aureus bacteremia is a common, serious infection, accurately identifying febrile patients with this diagnosis at the time of initial evaluation is difficult. The purpose of this investigation was to define clinical characteristics present at the time of the initial recognition of fever that were associated with the presence of any bloodstream infection and, in particular, with S. aureus bacteremia.

Methods

All patients ≥18 years of age with a new episode of health care-associated fever (temperature ≥38°C) and at least one blood culture drawn were eligible for enrollment into this prospective multicenter cohort study. Multivariable analyses were conducted and internally validated scoring systems were developed to categorize the risk of bacteremia.

Results

Of 1015 patients enrolled, 181 patients (17.8%) had clinically significant bacteremia, including 77 patients (7.6%) with S. aureus bacteremia. Clinical characteristics associated with S. aureus bacteremia were the presence of a hemodialysis graft or shunt (odds ratio [OR] 3.22; 95% confidence interval [CI], 1.85-5.61), chills (OR 2.38; 95% CI, 1.43-3.98), and a history of S. aureus infection (OR 2.68; 95% CI, 1.38-5.20). Peripheral vascular catheters were inversely associated with S. aureus bacteremia (OR 0.42; 95% CI, 0.26-0.69). Clinical characteristics associated with any bloodstream infection were central venous access, chills, history of S. aureus infection, and hemodialysis access.

Conclusions

Among patients with health care-associated fever, the presence of easily recognizable clinical characteristics at the time of obtaining the initial blood cultures can help to identify patients at increased risk for any bloodstream infection, in particular for S. aureus bacteremia.

Le texte complet de cet article est disponible en PDF.

Keywords : Bacteremia, Fever, Health care, S. aureus, Score


Plan


 Funding: This work was supported by a grant from Inhibitex, Inc. Inhibitex did not intervene in: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
 Conflicts of Interest: Martin E. Stryjewski has consulted for Astellas (<$10,000), and has received a research grant (>$10,000) and is a consultant for Theravance Inc. (>$10,000/year). Vivian H. Chu has received a research grant from Theravance Inc. Vance G. Fowler has received research funding from Theravance, Merck, Nabi (<US$10,000/year), Inhibitex, Cubist, and the National Institute of Health; is a consultant for Biosynexus, Inhibitex, Merck, Cerexa, and Cubist; and is on the speaker's bureaus for Cubist and Pfizer. G. Ralph Corey has received research funding from Theravance, Cubist, Merck, and Inhibitex; and is a consultant for Cubist, Inhibitex, Cerexa, and Pfizer. Daniel K. Benjamin Jr. has received a research grant from Nabi, Cape Cod Associates, Astellas, MedImmune, Pediatrix, Rockeby, National Institute of Child Health and Human Development, and National Institute of Allergy and Infectious Diseases. Tina Harding, Laura A. Drew, Paul A. Pappas, Benjamin A. Lee, Zeina A. Kanafani, and L. Barth Reller have no conflicts.
 Authorship: All authors had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.


© 2009  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 122 - N° 3

P. 281 - mars 2009 Retour au numéro
Article précédent Article précédent
  • Elevated Body Mass Index and Use of Coronary Revascularization after Cardiac Catheterization
  • Kathryn M. King, Danielle A. Southern, Jacques Cornuz, Andrew Maitland, Merril L. Knudtson, William A. Ghali
| Article suivant Article suivant
  • Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
  • David S. Wald, Malcolm Law, Joan K. Morris, Jonathan P. Bestwick, Nicholas J. Wald

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.